Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Conference, Product/Service, Trade Show

Stratasys Partners With Ricoh to Deliver Point-of-Care Anatomic Modeling Solution


Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing solutions, today announced a partnership with Ricoh USA, Inc. to provide point-of-care anatomic modeling services to healthcare facilities. RICOH 3D for Healthcare utilizes Stratasys 3D printing technology as part of its solution to give more medical providers and hospitals access to 3D printed, patient-specific anatomic models.

RICOH 3D for Healthcare is an end-to-end workflow that simplifies the development, design, and production of anatomic models1 for healthcare providers. The solution increases medical facility access to 3D printed medical models to help clinicians see inside anatomy for greater visibility into patient needs and reduces barriers to entry that healthcare providers encounter when standing up a 3D printing facility. These include staffing issues, training requirements, HIPAA, quality and IT compliance, as well as budget constraints.

Ricoh uses the Stratasys J750 Digital Anatomytm printer and the Stratasys J5 MediJettm 3D printer to create the models produced for RICOH 3D for Healthcare. The printers create life-like anatomic models that can reflect an individual patient's pathology and be physically manipulated like human tissue. Medical models allow clinicians to deliver more personalized care through better surgical preparation and patient education and can also be used for medical training purposes.

"To date, access to anatomic models at point-of-care locations has been limited to large hospitals and healthcare facilities," said Gary Turner, Managing Director, Ricoh 3D for Healthcare, Ricoh USA, Inc. "Our cost-effective solution expands access for healthcare providers of all sizes. By partnering with Stratasys, through an integration with IBM Watson Health and our ongoing commitment to innovation, we are able to provide these models to any facility using IBM iConnect® Access."

RICOH 3D for Healthcare is currently available to providers in two different ways. First, a point-of-care option, which includes having the Stratasys 3D printers coupled with Ricoh's managed services staff on-site to manage the entire process aligning with Ricoh's Quality Management System and good manufacturing practices. Further, there is an on-demand option where providers can order and have anatomic models 3D printed and shipped directly to them. Both options are HIPAA compliant and easy for medical staff to use.

"Through our partnership with Ricoh we are giving healthcare institutions the opportunity to access patient care tools that they may not have previously had access to," said Scott Drikakis, Healthcare Segment Leader for Stratasys. "With Ricoh 3D for Healthcare, providers can easily generate 3D printed models of patient specific anatomy using state of the art technology through an on-site managed services or on-demand part approach. This will demonstrate the clinical and economic benefits of anatomic models, while streamlining the historical challenges of establishing 3D printing programs in hospitals."

Attendees to the RSNA conference in Chicago Nov. 28 ? Dec. 2 can see the full anatomic model solution from IBM Watson Health, Ricoh and Stratasys in the IBM Watson Health 3D Printing Imaging Showcase in booth 8108.

Stratasys and Ricoh will continue to expand their partnership and redefine how healthcare facilities access anatomic models for personalized patient care. To learn more about Stratasys solutions for healthcare, visit www.stratasys.com/medical.

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world's leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the company's websites, to share material, non-public information pursuant to the SEC's Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys, Digital Anatomy, J750 and J5 Medi Jet are trademarks or registered trademarks of Stratasys Ltd. and/or its affiliates. All other trademarks are the property of their respective owners, and Stratasys assumes no responsibility with regard to the selection, performance, or use of these non-Stratasys products.

1The replicas are for non-diagnostic/treatment use.

Attention Editors, if you publish reader-contact information, please use:

 


These press releases may also interest you

at 03:01
Software industries worldwide endeavors to provide magnificent products with efficient functionality and outstanding performance. The software companies take the necessary steps to deliver optimal quality and innovative products by evaluating and...

at 03:00
Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the two companies have entered into an exclusive...

at 03:00
Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos's growth and deliver its...

at 02:30
The Last Mile Delivery market is segmented into two categories based on the service (B2C and B2B) and geography (North America, Europe, APAC, MEA, and South America). The market share is expected to increase by USD 146.96 billion from 2020 to 2025,...

at 02:20
Highlights of the full-year of 2021 In full-year 2021, strong price execution and attractive product and brand offering resulted in record net sales of SEK 125,631m (115,960), operating income excl. non-recurring items of SEK 7,528m (5,778), and...

at 02:11
Record high quarter driven by strong demand and strategic progressDividend proposal EUR 0.55 per share Q4/2021 (year-on-year) Sales increased by 26.3% to EUR 2,719 (2,154) million. Operational EBIT increased to EUR 426 (118) million. Operational EBIT...



News published on 1 november 2021 at 16:05 and distributed by: